结直肠癌数字化图像的定量病理分析改善无复发生存预测
研究对6468张结直肠癌数字化苏木精-伊红切片应用定量分割算法QuantCRC,记录15项参数并与临床病理特征及分子改变关联。基于内部队列(n=1928)建立预后模型,在内部测试集(n=483)和外部队列(n=938)验证,结果显示纳入QuantCRC的模型提高无复发生存预测的c-index,并识别出预后风险组。
要点
- QuantCRC参数与分期、组织学亚型、分级、脉管/神经侵犯、肿瘤出芽、错配修复状态及KRAS/BRAF突变等显著相关。
- 含分期、错配修复和QuantCRC的预后模型在外部队列c-index为0.744(95%CI 0.741-0.754)。
- 外部队列中高危III期结直肠癌预测36个月复发率为32.7%,低危III期为13.4%。
核心结论
- QuantCRC为结直肠癌常规病理报告提供了强有力的辅助工具,使用QuantCRC的预后模型改善了无复发生存预测。
研究设计与样本
- 对6468张结直肠癌数字化苏木精-伊红切片应用定量分割算法QuantCRC,每张图像记录15项参数。
- 利用内部队列(n=1928)数据建立预后模型,在内部测试集(n=483)和外部队列(n=938)进行验证。
主要发现
- QuantCRC参数在分期、组织学亚型、分级、静脉/淋巴管/神经周围侵犯、肿瘤出芽、CD8免疫组化、错配修复状态、KRAS突变、BRAF突变和CpG甲基化间存在显著差异。
- 含分期、错配修复和QuantCRC的预后模型在内部测试集Harrell一致性指数为0.714(95%CI 0.702-0.724),外部队列为0.744(95%CI 0.741-0.754)。
- 从模型中移除QuantCRC后,外部队列c-index降至0.679(95%CI 0.673-0.694)。
- 外部队列校正已确立风险因素后,低风险 vs 高风险III期结直肠癌的风险比为2.24(95%CI 1.33-3.87,P=0.004),低风险 vs 高风险II期结直肠癌的风险比为2.36(95%CI 1.07-5.20,P=0.03)。
- 外部队列中,高风险III期结直肠癌预测36个月复发率为32.7%,低风险III期为13.4%;高风险II期结直肠癌预测36个月复发率为15.8%,低风险II期为5.4%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: To examine whether quantitative pathologic analysis of digitized hematoxylin and eosin slides of colorectal carcinoma (CRC) correlates with clinicopathologic features, molecular alterations, and prognosis. METHODS: A quantitative segmentation algorithm (QuantCRC) was applied to 6468 digitized hematoxylin and eosin slides of CRCs. Fifteen parameters were recorded from each image and tested for associations with clinicopathologic features and molecular alterations. A prognostic model was developed to predict recurrence-free survival using data from the internal cohort (n = 1928) and validated on an internal test (n = 483) and external cohort (n = 938). RESULTS: There were significant differences in QuantCRC according to stage, histologic subtype, grade, venous/lymphatic/perineural invasion, tumor budding, CD8 immunohistochemistry, mismatch repair status, KRAS mutation, BRAF mutation, and CpG methylation. A prognostic model incorporating stage, mismatch repair, and QuantCRC resulted in a Harrell's concordance (c)-index of 0.714 (95% confidence interval [CI], 0.702-0.724) in the internal test and 0.744 (95% CI, 0.741-0.754) in the external cohort. Removing QuantCRC from the model reduced the c-index to 0.679 (95% CI, 0.673-0.694) in the external cohort. Prognostic risk groups were identified, which provided a hazard ratio of 2.24 (95% CI, 1.33-3.87, P = .004) for low vs high-risk stage III CRCs and 2.36 (95% CI, 1.07-5.20, P = .03) for low vs high-risk stage II CRCs, in the external cohort after adjusting for established risk factors. The predicted median 36-month recurrence rate for high-risk stage III CRCs was 32.7% vs 13.4% for low-risk stage III and 15.8% for high-risk stage II vs 5.4% for low-risk stage II CRCs. CONCLUSIONS: QuantCRC provides a powerful adjunct to routine pathologic reporting of CRC. A prognostic model using QuantCRC improves prediction of recurrence-free survival.
引用
- Pai RK, Banerjee I, Shivji S, et al. Quantitative Pathologic Analysis of Digitized Images of Colorectal Carcinoma Improves Prediction of Recurrence-Free Survival. Gastroenterology. 2022. PMID: 35985511. doi:10.1053/j.gastro.2022.08.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。